- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03500965
Pictorial Warning Labels and Memory for Relative and Absolute Cigarette Health-risk Information Over Time in Teens
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- have ever tried smoking
- report vulnerability to smoking (i.e., report that they might smoke in the next year or would try a cigarette if a friend offered one)
- parents give permission to participate
Exclusion Criteria:
- not vulnerable to smoking (i.e., report they will definitely not smoke a cigarette in the next year and definitely would not try a cigarette if one was offered
- parents do not provide permission to participate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Text-only PWL, absol risk
Exposure to FDA-mandated warning labels, without a graphic image, accompanied by risk information about smoker's risk of a smoking-related disease
|
control condition (no image)
Percentage risk information for smoking-related diseases for smokers
|
Experimental: text-only PWL, relative risk
Exposure to FDA-mandated warning labels, without a graphic image, accompanied by risk information about smoker's risk and non-smoker's risk of a smoking-related disease
|
control condition (no image)
Percentage risk information for smoking-related diseases for smokers and non-smokers
|
Experimental: graphic PWL, absol risk
Exposure to FDA-mandated warning labels, paired with a graphic image, accompanied by risk information about smoker's risk of a smoking-related disease
|
Percentage risk information for smoking-related diseases for smokers
pictorial warning
|
Experimental: graphic PWL, relative risk
Exposure to FDA-mandated warning labels, paired with a graphic image, accompanied by risk information about smoker's risk and non-smoker's risk of a smoking-related disease
|
Percentage risk information for smoking-related diseases for smokers and non-smokers
pictorial warning
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
numeric risk recognition
Time Frame: measured immediately following last exposure
|
Participants answered one multiple choice question about the numeric risk for smokers for each label (e.g., ____% of smokers die before age 85).
For each question, there were four decoy responses.
|
measured immediately following last exposure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
numeric risk recognition
Time Frame: measured after 6-week delay
|
Participants answered one multiple choice question about the numeric risk for smokers for each label (e.g., ____% of smokers die before age 85).
For each question, there were four decoy responses.
|
measured after 6-week delay
|
relative risk recognition
Time Frame: measured immediately following last exposure
|
Participants answered one multiple choice question about the numeric risk for smokers vs. nonsmokers for each health risk (e.g., a smoker is ____ as likely to die from heart disease as a nonsmoker).
For each question, there were three decoy responses (e.g., for heart disease, response options were: "about as likely," "1.75 times," "4.1 times," "10.4 times").
|
measured immediately following last exposure
|
relative risk recognition
Time Frame: measured after 6-week delay
|
Participants answered one multiple choice question about the numeric risk for smokers vs. nonsmokers for each health risk (e.g., a smoker is ____ as likely to die from heart disease as a nonsmoker).
For each question, there were three decoy responses (e.g., for heart disease, response options were: "about as likely," "1.75 times," "4.1 times," "10.4 times").
|
measured after 6-week delay
|
smoking risk perceptions
Time Frame: measured immediately following last exposure
|
Participants completed several scale items about how much risk they perceived smoking posed to them (e.g., "If a person smokes at your age, how likely are they to get a life-threatening illness from smoking someday ?" [1=very unlikely; 5=extremely likely])
|
measured immediately following last exposure
|
smoking risk perceptions
Time Frame: measured after 6-week delay
|
Participants completed several scale items about how much risk they perceived smoking posed to them (e.g., "If a person smokes at your age, how likely are they to get a life-threatening illness from smoking someday ?" [1=very unlikely; 5=extremely likely])
|
measured after 6-week delay
|
risk recognition
Time Frame: measured immediately following last exposure
|
Participants were given a list of 9 warnings and asked to select which ones they'd been previously exposed to
|
measured immediately following last exposure
|
risk recognition
Time Frame: measured after 6-week delay
|
Participants were given a list of 9 warnings and asked to select which ones they'd been previously exposed to
|
measured after 6-week delay
|
feelings about smoking
Time Frame: measured immediately following last exposure
|
Participants completed several scale items about their feelings towards smoking (e.g., "How good or bad do you feel about smoking?" -2=very bad; +2=very good; "How much do you feel confused about the harms vs. benefits of smoking?" 0=not at all confused; 4=very confused)
|
measured immediately following last exposure
|
feelings about smoking
Time Frame: measured after 6-week delay
|
Participants completed several scale items about their feelings towards smoking (e.g., "How good or bad do you feel about smoking?" -2=very bad; +2=very good; "How much do you feel confused about the harms vs. benefits of smoking?" 0=not at all confused; 4=very confused)
|
measured after 6-week delay
|
quit intentions (for next 30 days)
Time Frame: measured immediately following last exposure
|
Participants intentions to quit smoking; self-reported likelihood of smoking "within the next 30 days" (-3 = very unlikely, 3 = very likely) (only for those teens who currently smoked) |
measured immediately following last exposure
|
quit intentions (for next 30 days)
Time Frame: measured after 6-week delay
|
Participants intentions to quit smoking; self-reported likelihood of smoking "within the next 30 days" (-3 = very unlikely, 3 = very likely) (only for those teens who currently smoked) |
measured after 6-week delay
|
quit intentions (for next year)
Time Frame: measured immediately following last exposure
|
Participants intentions to quit smoking; self-reported likelihood of smoking "within the next year" (-3 = very unlikely, 3 = very likely) only for those teens who currently smoked |
measured immediately following last exposure
|
quit intentions (for next year)
Time Frame: measured after 6-week delay
|
Participants intentions to quit smoking; self-reported likelihood of smoking "within the next year" (-3 = very unlikely, 3 = very likely) only for those teens who currently smoked |
measured after 6-week delay
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- P50CA180908A2a-T
- P50CA180908 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
The University of Hong KongNot yet recruitingSmoking Cessation Counseling Ability | Smoking Cessation Counseling PracticeHong Kong
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
-
University of Wisconsin, MadisonCentiment LLCCompletedSmoking | Smoking CessationUnited States
-
Yale UniversityCompletedSmoking | Smoking CessationUnited States
Clinical Trials on text-only PWL
-
Ohio State UniversityUniversity of PennsylvaniaCompletedSmoking Cessation | Smoking, Cigarette
-
Ohio State UniversityUniversity of PennsylvaniaCompletedSmoking Cessation | Smoking, Cigarette
-
Ohio State UniversityUniversity of PennsylvaniaCompletedSmoking Cessation | Smoking, CigaretteUnited States
-
Duke UniversityCompleted
-
Stanford UniversityHarvard Pilgrim Health CareCompleted
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); University of California, Davis; University... and other collaboratorsActive, not recruitingEducational ActivitiesUnited States
-
Boston UniversityNational Cancer Institute (NCI); Brown University; National Institutes of Health... and other collaboratorsCompleted
-
University of PittsburghCompleted
-
University of CincinnatiFoundation for Informed Medical Decision MakingCompletedCoronary Artery DiseaseUnited States
-
University of PennsylvaniaCompleted